FAQ: Kalshi's Cancer Drug Betting Markets Raise Ethics Concerns

Kalshi, a prediction betting market app, announced new contracts in July 2026 for FDA approvals on various cancer and multispecialty drugs and the progression/outcomes of phase 1–3 clinical trials.¹ However, these contracts caused many leaders in the field, like clinical trial navigators, to question their ethics.